Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr;35(2):222-224.
doi: 10.5114/ada.2018.75249. Epub 2018 Apr 24.

A desensitization protocol for delayed allergy to cytarabine: analysis of two cases

Affiliations

A desensitization protocol for delayed allergy to cytarabine: analysis of two cases

Marcello Albanesi et al. Postepy Dermatol Alergol. 2018 Apr.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
A, B – Representative pictures of cutaneous lesions for case 1 and case 2. Similar lesions were scattered on the whole body. As for case 1, the lesion shown does not correspond to the site of injection of cytarabine. C – Case 2. Lymphocyte proliferation assessed after 5 days of culture with the indicated concentrations of cytarabine or phytohemagglutinin M (PHA-M). The ratio between the different cytarabine concentrations and negative control is shown above each Histogramm column. Error bars correspond to SEM. D – A dose-time desensitization curve of cytarabine

References

    1. Castleberry RP, Crist WM, Holbrook T, et al. The cytosine arabinoside (Ara-C) syndrome. Med Pediatr Oncol. 1981;9:257–64. - PubMed
    1. Shepherd GM. Hypersensitivity reactions to chemotherapeutic drugs. Clin Rev Allergy Immunol. 2003;24:253–62. - PubMed
    1. Cacoub P, Musette P, Descamps V, et al. The DRESS syndrome: a literature review. Am J Med. 2011;124:588–97.. - PubMed
    1. Rassiga AL, Schwartz HJ, Forman WB, Crum ED. Cytarabine-induced anaphylaxis. Demonstration of antibody and successful desensitization. Arch Intern Med. 1980;140:425–6. - PubMed
    1. Ozkan A, Apak H, Celkan T, et al. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside. Pediatr Dermatol. 2001;18:38–40. - PubMed

LinkOut - more resources